A Study of NX-1607 in Adults With Advanced Malignancies

Clinical trial NCT05107674 · RECRUITING

Trial details

NCT number: NCT05107674
Sponsor: Nurix Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer, Epithelial Gastric Cancer GastroEsophageal Junction (GEJ) Cancer Head and Neck Squamous Cell Carcinoma Metastatic or Unresectable Melanoma Non-small Cell Lung Cancer (NSCLC)Metastatic Castration-resistant Prostate Cancer (mCRPC)Malignant Pleural Mesothelioma (MPM)Triple Negative Breast Cancer (TNBC)Metastatic Urothelial Carcinoma Cervical Cancer Diffuse Large B Cell Lymphoma (DLBCL)

Start date: 2021-09-29
Primary completion: 2026-08-31
Enrollment: 345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.